Cargando…

Lymphocyte Landscape after Chronic Hepatitis C Virus (HCV) Cure: The New Normal

Chronic HCV (CHC) infection is the only chronic viral infection for which curative treatments have been discovered. These direct acting antiviral (DAA) agents target specific steps in the viral replication cycle with remarkable efficacy and result in sustained virologic response (SVR) or cure in hig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Alip, Romani, Sara, Kottilil, Shyam, Poonia, Bhawna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589490/ https://www.ncbi.nlm.nih.gov/pubmed/33050486 http://dx.doi.org/10.3390/ijms21207473

Ejemplares similares

Peripheral PD-1(+) T Cells Co-expressing Inhibitory Receptors Predict SVR With Ultra Short Duration DAA Therapy in HCV Infection
por: Romani, Sara, et al.
Publicado: (2019)

Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients
por: Kim, Jin Hyang, et al.
Publicado: (2020)

Publisher Correction: Circulating serum HBsAg level is a biomarker for HBV-specific T and B cell responses in chronic hepatitis B patients
por: Kim, Jin Hyang, et al.
Publicado: (2020)

CD38: an ecto-enzyme with functional diversity in T cells
por: Ghosh, Alip, et al.
Publicado: (2023)

Short‐duration treatment with the novel non‐nucleoside inhibitor CDI‐31244 plus sofosbuvir/velpatasvir for chronic hepatitis C: An open‐label study
por: Chua, Joel V., et al.
Publicado: (2020)

Blockade of CCR4 breaks immune tolerance in chronic hepatitis B patients by modulating regulatory pathways
por: Khanam, Arshi, et al.
Publicado: (2023)

2072. Of Mice and Men: HIV-induced CD38 expression on CD8+ T lymphocytes contributes to mitochondrial dysfunction and chronic inflammation despite antiretroviral therapy
por: Mathur, Poonam, et al.
Publicado: (2022)

IL-21–Deficient T Follicular Helper Cells Support B Cell Responses Through IL-27 in Patients With Chronic Hepatitis B
por: Khanam, Arshi, et al.
Publicado: (2021)

Oral Selective TLR8 Agonist Selgantolimod Induces Multiple Immune Cell Responses in Humans
por: Ayithan, Natarajan, et al.
Publicado: (2021)

Immune Correlates of COVID-19 Control
por: Poonia, Bhawna, et al.
Publicado: (2020)

Tickling the TLR7 to cure viral hepatitis
por: Funk, Emily, et al.
Publicado: (2014)

CCR5 receptor antagonism inhibits hepatitis C virus (HCV) replication in vitro
por: Blackard, Jason T., et al.
Publicado: (2019)

1060. Evaluation of ALT at Sustained Virologic Response (SVR) in Patients with Treated Hepatitis C Virus (HCV) Infection
por: Theppote, Amanda, et al.
Publicado: (2020)

Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis
por: Comstock, Emily, et al.
Publicado: (2017)

Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
por: Khanam, Arshi, et al.
Publicado: (2021)

A Phase 2 open label study of ledipasvir/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection
por: Price, Angie S., et al.
Publicado: (2022)

Follicular Helper T (T(FH)) Cell Targeting by TLR8 Signaling For Improving HBsAg-Specific B Cell Response In Chronic Hepatitis B Patients
por: Ayithan, Natarajan, et al.
Publicado: (2021)

HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
por: Poonia, Bhawna, et al.
Publicado: (2018)

Rapid changes in peripheral lymphocyte concentrations during interferon‐free treatment of chronic hepatitis C virus infection
por: Meissner, Eric G., et al.
Publicado: (2017)

Inflammatory and cardiovascular diseases biomarkers in chronic hepatitis C virus infection: A review
por: Babiker, Ahmed, et al.
Publicado: (2019)

Multitarget Direct‐Acting Antiviral Therapy Is Associated With Superior Immunologic Recovery in Patients Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus
por: Shrivastava, Shikha, et al.
Publicado: (2018)

On-Treatment Elevation in Hepatic Transaminases during HCV Treatment with Ombitasvir, Paritaprevir, Dasabuvir, Ritonavir, and Ribavirin: A Case Series
por: Bean, Madelyne, et al.
Publicado: (2016)

CCR5+ T-Cells Homed to the Liver Exhibit Inflammatory and Profibrogenic Signatures in Chronic HIV/HCV-Coinfected Patients
por: Shrivastava, Shikha, et al.
Publicado: (2021)

158 Hepatitis C Treatment Update: Current Status and Future Direcctions
por: Kottilil, Shyam
Publicado: (2014)

Synergistic impact of mutations in Hepatitis B Virus genome contribute to its occult phenotype in chronic Hepatitis C Virus carriers
por: Mondal, Rajiv Kumar, et al.
Publicado: (2017)

Liver Stiffness Hinders Normalization of Systemic Inflammation and Endothelial Activation after Hepatitis C Virus (HCV) Eradication in HIV/HCV Coinfected Patients
por: Álvarez, Beatriz, et al.
Publicado: (2020)

Systemic manifestations of hepatitis C infection
por: Tang, Lydia, et al.
Publicado: (2016)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
por: Yoon, Eugene J., et al.
Publicado: (2006)

Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients
por: Kushner, Lauren E., et al.
Publicado: (2013)

HCV cure without interferon
por: Bourlière, Marc
Publicado: (2014)

Epidemiology of Hepatitis C Virus (HCV) Infection
por: Sy, Theodore, et al.
Publicado: (2006)

Chronic Hepatitis C Virus (HCV) Disease Burden and Cost in the United States
por: Razavi, Homie, et al.
Publicado: (2013)

Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression
por: Khanam, Arshi, et al.
Publicado: (2021)

Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experience
por: Cho, Eun Ju, et al.
Publicado: (2012)

Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection
por: Liu, Zhihua, et al.
Publicado: (2006)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
por: Orr, Cody, et al.
Publicado: (2020)

Chronic hepatitis C virus (HCV) increases the risk of chronic kidney disease (CKD) while effective HCV treatment decreases the incidence of CKD
por: Park, Haesuk, et al.
Publicado: (2017)

GP73 Is Upregulated by Hepatitis C Virus (HCV) Infection and Enhances HCV Secretion
por: Hu, Longbo, et al.
Publicado: (2014)

Hepatitis C virus screening in Piemonte: an effective strategy to eliminate HCV chronic infections
por: Thomas, R, et al.
Publicado: (2023)

The Natural History of Hepatitis C Virus (HCV) Infection
por: Chen, Stephen L., et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_j051dpetji2b618u048qag0mgm